Impact of traditional and ankylosing spondylitisassociated risk factors on the formation of atherosclerotic lesions in the brachiocephalic arteries
https://doi.org/10.29001/2073-8552-2020-35-1-117-124
Abstract
Objective. To study the risk factors associated with carotid atherosclerotic lesions in ankylosing spondylitis.
Material and Methods. The study included 32 male patients with AS who underwent a general clinical examination. In these patients, traditional factors of cardiovascular risk were identified; the activity and functional status of the disease were determined. To identify atherosclerotic lesions of the carotid arteries, Doppler ultrasound was used to measure carotid intima-media thickness and to identify atherosclerotic plaques.
Results. The carotid intima-media thickness (CIMT) in the group was 0.9 mm [0.7; 1.2]; the median age was 38.2 years [32.0; 43.5]. With the application of age and sex norms, an increase in CIMT was observed in 80.6% of patients. The correlation analysis of the structure of traditional risk factors demonstrated the significant associations of CIMT with age (r = 0.609, р < 0.0001), body mass index (r = 0.439, p = 0.013), glucose level (r = 0.528, p = 0.002), triglycerides (r = 0.458, p = 0.010), and total cholesterol (r = 0.398, p = 0.027). High rates of smoking (6 out of 16 against 14 out of 16, χ2 = 7.888, p = 0.009) and arterial hypertension (4 out of 16 against 10 out of 16, χ2 = 7.630, p = 0.009) were found mostly in the group with increased CIMT. No significant differences and relationships of CIMT with disease activity indicators and antirheumatic therapy were revealed. Significant relationships were found between the atherosclerotic lesions of the carotid arteries in patients with AS with the duration of the disease (r = 0.370, p = 0.041) and functional status assessed using the BASFI index (r = 0.507,
p = 0.004).
Conclusions. The study revealed a high prevalence of traditional cardiovascular risk factors among patients with AS, as well as the significant associations of the duration of the disease and the degree of functional impairment with the formation of carotid atherosclerotic lesions. The results of the study suggest that a more thorough assessment of CVD risk, as well as the use of additional objective criteria, are necessary for patients with AS.
About the Authors
A. Ya. DimitrenkoRussian Federation
Internal Medicine Resident, Center for Postgraduate Medical Education
1, Pirogova str., Novosibirsk, 630090, Russian Federation
V. O. Omelchenko
Russian Federation
Rheumatologist, Internist, Junior Research Scientist, Laboratory of Connective Tissue Disease
2, Timakova str., Novosibirsk, 630117, Russian Federation
E. A. Letyagina
Russian Federation
M.D., Cand. Sci. (Med.), Rheumatologist, Internist, Head of the Rheumatology Department of the RICEL Clinic; Senior Research Scientist, Laboratory of Connective Tissue Disease
2, Timakova str., Novosibirsk, 630117, Russian Federation
M. A. Korolev
Russian Federation
M.D., Cand. Sci. (Med.), Rheumatologist, Head of the Laboratory of Connective Tissue Disease
2, Timakova str., Novosibirsk, 630117, Russian Federation
References
1. Rebrov A.P., Gaidulova I.Z., Poddubnyi D.A. Cardiovascular disease in patients with ankylosing spondylitis. Rheumatology Science and Practice. 2012;51(2):100–105 (In Russ.).
2. Zambrano-Zaragoza J.F., Agraz-Cibrian J.M., González-Reyes C., Durán-Avelar Ma. de J., Vibanco-Pérez N. Ankylosing spondylitis: from cells to genes. International Journal of Inflammation. 2013;501653:16. DOI: 10.1155/2013/501653.
3. Hung Y.M., Chang W.P., Wei J.C., Chou P., Wang P.Y. Midlife ankylosing spondylitis increases the risk of cardiovascular diseases in males 5 years later: a national population-based study. Medicine (Baltimore). 2016;95(18):e3596. DOI: 10.1097/MD.0000000000003596.
4. Gupta N., Saigal R., Goyal L., Agrawal A., Bhargava R., Agrawal A. Carotid intima media thickness as a marker of atherosclerosis in ankylosing spondylitis. International Journal of Rheumatology. 2014; 839135:5. DOI: 10.1155/2014/839135.
5. Ungprasert P., Srivali N., Kittanamongkolchai W. Risk of coronary artery disease in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann. Transl. Med. 2015;3(4):51. DOI: 10.3978/j.issn.2305-5839.2015.02.05.
6. Rueda-Gotor J., Llorca J., Corrales A., Blanco R., Fuentevilla P., Portilla V. et al. Carotid ultrasound in the cardiovascular risk stratification of patients with ankylosing spondylitis: results of a population-based study. Clin. Exp. Rheumatol. 2016;34(5):885–892.
7. Skare T.L., Verceze G.C., de Oliveira A.A., Perreto S. Carotid intima-media thickness in spondyloarthritis patients. Sao Paulo Med. J. 2013;131(2):100–105.
8. Omelchenko V.O., Korolev M.A., Pospelova T.I., Konenkov V.I. Cardiovascular risk for rheumatoid arthritis. Clinical Medicine. 2018;96(6):491–497 (In Russ.).
9. Arida A., Protogerou A.D., Kitas G.D., Sfikakis P.P. Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases. Int. J. Mol. Sci. 2018;19(7):1890. DOI: 10.3390/ijms19071890.
10. Malyutina S.K., Ryabikov A.N., Palekhina Y.Y., Shakhmatov S.G., Ryabikov M.N., Guseva V.P. Sex- and age-specific reference criteria for the intima-media thickness of carotid arteries in a typical Russian population. Ultrasound and Functional Diagnostics. 2015;5:64–65 (In Russ.). https://rucont.ru/efd/503001.
11. Travnikova N.Y., Ragino Y.I., Kovalkova N.A., Voevoda M.I. Abdominal obesity, metabolic syndrome and respiratory function disturbance. The Siberian Scientific Medical Journal. 2015;35(5):41–46 (In Russ.).
12. Toy S., Ozbag D., Altay Z. The effects of pre-obesity on quality of life, disease activity, and functional status in patients with ankylosing spondylitis. North. Clin. İstanb. 2017;4(1):52–59. DOI: 10.14744/nci.2017.27122.
13. Forny-Germano L., De Felice F.G., do Nascimento Vieira M.N. The role of leptin and adiponectin in obesity-associated cognitive decline and Alzheimer’s disease. Front. Neurosci. 2019;12:1027. DOI: 10.3389/fnins.2018.01027.
14. Nagy G., Németh N., Buzás E.I. Mechanisms of vascular comorbidity in autoimmune diseases. Curr. Opin. Rheumatol. 2018;30(2):197–206. DOI: 10.1097/BOR.0000000000000483.
15. Glintborg B., Højgaard P., Hetland M.L., Krogh N.S., Kollerup G., Jensen J. et al. Impact of tobacco smoking on response to tumour necrosis factor-alpha inhibitor treatment in patients with ankylosing spondylitis: results from the Danish nationwide DANBIO registry. Rheumatology. 2016;55(4):659–668. DOI: 10.1093/rheumatology/kev392.
16. Moltó A., Nikiphorou E. Comorbidities in Spondyloarthritis. Front. Med. (Lausanne). 2018;5:62. DOI: 10.3389/fmed.2018.00062.
17. Rollefstad S., Ikdahl E., Hisdal J., Kvien T.K., Pedersen T.R., Semb A.G. Association of chest pain and risk of cardiovascular disease with coronary atherosclerosis in patients with inflammatory joint diseases. Front. Med. (Lausanne). 2015;2:80. DOI: 10.3389/fmed.2015.00080.
18. Tsui F.W., Tsui H.W., Akram A., Haroon N., Inman R.D. The genetic basis of ankylosing spondylitis: new insights into disease pathogenesis. Appl. Clin. Genet. 2014;7:105–115. DOI: 10.2147/TACG.S37325.
19. Ghasemi-Rad M., Attaya H., Lesha E., Vegh A., Maleki-Miandoab T., Nosair E. et al. Ankylosing spondylitis: A state of the art factual backbone. World J. Radiol. 2015;7(9):236–252. DOI: 10.4329/wjr.v7.i9.236.
Review
For citations:
Dimitrenko A.Ya., Omelchenko V.O., Letyagina E.A., Korolev M.A. Impact of traditional and ankylosing spondylitisassociated risk factors on the formation of atherosclerotic lesions in the brachiocephalic arteries. Siberian Journal of Clinical and Experimental Medicine. 2020;35(1):117-124. (In Russ.) https://doi.org/10.29001/2073-8552-2020-35-1-117-124